INFECTION OF HTLV-1-SPECIFIC IMMUNE T-CELL CLONES BY HTLV-I
HTLV-I 对 HTLV-1 特异性免疫 T 细胞克隆的感染
基本信息
- 批准号:3963326
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:cell growth regulation cell transformation clone cells helper T lymphocyte human T cell leukemia human T cell lymphotropic virus type 1 human tissue interleukin 2 leukocyte activation /transformation neoplasm /cancer immunology oncogenic virus provirus suppressor T lymphocyte transforming virus viral leukemia viral leukemogenesis virus infection mechanism
项目摘要
Human T-lymphotropic virus-I (HTLV-I)-specific T-cell lines were
established and cloned. An OKT8+ cytotoxic clone (K5) was specifically
reactive against HTLV-I-bearing autologous tumor cells, and it retained a
normal dependence on interluekin 2 (IL-2). We observed multiple proviral
integration sites in K5 cells (i.e., there was no dominant proviral
integration site), suggesting that the number of integration sites which,
when occupied, result in T-cell transformation is finite. An OKT4+
HTLV-I-infected clone (R2) mounted a specific proliferative response to
HTLV-I; however, its IL-2-independent proliferation increased with time and
the antigen-specificity was eventually lost. All HTLV-I-infected clones
tested including another OKT8+ transformed cytotoxic clone (K7) which had
lost its reactivity against HTLV-I, expressed T-cell receptor B chain
(TCR-B) messenger RNA at comparable levels. Two clones (K5 and K7) had the
same rearrangement of the TCR-B gene, suggesting that they have the same
clonal origin, even though they exhibited different functional properties
following HTLV-I infection.
These data indicate that HTLV-I-specific immune T-cell clones with a range
of functions can be infected with HTLV-I, retain their immune reactivity
for variable periods of time in culture, and lose it, although in some
cases no alteration in function following HTLV-I infection can be
detected. In addition, the data suggest that different consequences can
take place in the same clone depending on the pattern of retroviral
infection.
人嗜T淋巴细胞病毒-I(HTLV-I)特异性T细胞系是
建立和克隆。 OKT 8+细胞毒性克隆(K5)特异性地被
对携带HTLV-I的自体肿瘤细胞具有反应性,并且它保留了
正常依赖白细胞介素2(IL-2)。 我们观察到多个前病毒
K5细胞中的整合位点(即,没有显性前病毒
整合位点),表明整合位点的数量,
当被占用时,导致T细胞转化是有限的。 OKT 4 +
HTLV-I感染的克隆(R2)对HTLV-I产生特异性增殖反应,
然而,其IL-2非依赖性增殖随着时间的推移而增加,
抗原特异性最终丧失。 所有HTLV-I感染的克隆
测试包括另一个OKT 8+转化的细胞毒性克隆(K7),
失去对HTLV-1的反应性,表达T细胞受体B链
(TCR-B)信使RNA在相当的水平。 两个克隆(K5和K7)具有
TCR-B基因的相同重排,表明它们具有相同的
克隆起源,即使它们表现出不同的功能特性,
HTLV-I感染后。
这些数据表明,HTLV-I特异性免疫T细胞克隆具有一定的
的功能可以感染HTLV-I,保留其免疫反应性
在文化中的可变时间段,并失去它,虽然在一些
HTLV-I感染后功能无改变的病例,
检测到 此外,数据表明,不同的后果可以
发生在同一个克隆中,这取决于逆转录病毒的模式,
感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H MITSUYA其他文献
H MITSUYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H MITSUYA', 18)}}的其他基金
PROFILES OF DRUG SENSITIVITY OF HIV-1 ISOLATES IN PATIENTS RECEIVING ANTIVIRALS
接受抗病毒药物治疗的患者中 HIV-1 分离株的药物敏感性概况
- 批准号:
3838136 - 财政年份:
- 资助金额:
-- - 项目类别:
INHIBITION OF HEPATITIS B VIRUS REPLICATION BY DIDEOXYNUCLEOSIDES
双脱氧核苷对乙型肝炎病毒复制的抑制
- 批准号:
3838139 - 财政年份:
- 资助金额:
-- - 项目类别:
DEVELOPMENT OF RESISTANCE OF HIV IN PATIENTS RECEIVING AZT, DDC, OR DDI
接受 AZT、DDC 或 DDI 的患者出现 HIV 耐药性
- 批准号:
3853268 - 财政年份:
- 资助金额:
-- - 项目类别:
IN VITRO INHIBITION OF HIV BY COMBINATION OF MULTIPLE ANTI-HIV AGENTS
多种抗 HIV 药物的组合对 HIV 的体外抑制
- 批准号:
3874494 - 财政年份:
- 资助金额:
-- - 项目类别:
QUANTITATIVE ANALYSIS OF HIV-1 PROVIRAL DNA IN SAMPLES FROM PATIENTS WITH AIDS
艾滋病患者样本中 HIV-1 前病毒 DNA 的定量分析
- 批准号:
3874497 - 财政年份:
- 资助金额:
-- - 项目类别:
INHIBITION OF HIV-1 REPLICATION BY C2 SYMMETRIC HIV PROTEASE INHIBITORS
C2 对称 HIV 蛋白酶抑制剂对 HIV-1 复制的抑制
- 批准号:
3774654 - 财政年份:
- 资助金额:
-- - 项目类别:
THE EFFECT OF DNA DEMETHYLATION HIV-1 EXPRESSION IN VITRO
DNA 去甲基化对 HIV-1 体外表达的影响
- 批准号:
3853267 - 财政年份:
- 资助金额:
-- - 项目类别:
SYNTHESIS AND IN VITRO ANTI-HIV ACTIVITY OF LIPOPHILIC DIDEOXYNUCLEOSIDES
亲脂性双脱氧核苷的合成及其体外抗HIV活性
- 批准号:
3838140 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Elucidation of the pathogenesis of cancer stem cell transformation and acquisition of therapeutic resistance in lung cancer via the Hedgehog signaling system
通过 Hedgehog 信号系统阐明肺癌干细胞转化和获得治疗耐药性的发病机制
- 批准号:
23K08304 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanism of cell transformation by aconitase
乌头酸酶转化细胞的机制
- 批准号:
494625 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
A novel treatment for eosinophilic otitis media by suppression of goblet cell transformation
通过抑制杯状细胞转化治疗嗜酸性中耳炎的新方法
- 批准号:
22K09710 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of lung cancer stem cell transformation and treatment resistance
阐明肺癌干细胞转化及治疗耐药机制
- 批准号:
21K16527 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
proteomic analysis of smooth muscle cell transformation in obstructive lesions of pulmonary hypertension.
肺动脉高压阻塞性病变中平滑肌细胞转化的蛋白质组学分析。
- 批准号:
20K08155 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.
EMT 转录因子在表观遗传重塑和骨髓细胞转化中的作用。
- 批准号:
nhmrc : GNT1141081 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Project Grants
Roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.
EMT 转录因子在表观遗传重塑和骨髓细胞转化中的作用。
- 批准号:
nhmrc : 1141081 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Project Grants